I can't wait for people to catch on to this company and stock.

NBY has a market cap of $50 million. That is absolute chump change for a company with their potential. Staph infections kill 100,000+ people per year in our hospitals. Over the next several years, NBY's products are likely to become a standard of care for all our hospitals to prevent these needless deaths. In addition to preventative care for staph infections, they will likely have products for acne, nail fungus, eye infections, etc., etc.

Don't sell this stock after a 50 cent run. You will regret it.